Supply RP1 to Incyte for the clinical trial
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 3 Aug 2023
- Due
- 31 Mar 2024
- Checked
- 1 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Replimune will supply Incyte with RP1 for the study”
What we found
Evidence strength A What the grades mean
The company did not supply RP1 to Incyte before the agreement was terminated on August 1, 2024, following Incyte's decision to discontinue the study drug's development.
-
A Replimune Group, Inc. 10-Q filed 2025-02-12
“On August 1, 2024, the Company received notice of termination of the Clinical Trial Collaboration and Supply Agreement from Incyte.” ✓ confirmed on the page
-
A Replimune Group, Inc. 10-Q filed 2025-02-12
“During the year ended March 31, 2024, the Company did not make any payments to, or receive any payments from, Inctye under the terms of the agreement.” ✓ confirmed on the page
Market reaction: the shares moved +9.0% against the S&P 500 over the three sessions around the disclosure (11 Feb 2025 to 14 Feb 2025). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Supply
- Deliverable
- RP1 supply
- Language
- Firm (“will”, “on track to”)
- In the company’s control
- High
- Specificity
- Medium
- Conditional
- Yes: subject to clinical trial initiation
- Depends on
- Partner
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Withdrawn”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Replimune Group, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-REPL-002721 · Corrections policy